Gregory Rossi

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Lowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins et al. · Journal of Clinical Oncology · 2015 · 905 citations

Public Affairs, Health Policy, Oncology +17

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

Lowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins et al. · Journal of Clinical Oncology · 2016 · 655 citations

Pharmacy, Oncology, Pharmacoeconomics +13

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

Michael Hedenus, Magnus Adriansson, Jesús F. San Miguel et al. · British Journal of Haematology · 2003 · 326 citations · Full text

Medicine, Hematology, Pharmacology +10

Randomized, dose‐finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

Michael Hedenus, Kerry Taylor, Chris Arthur et al. · British Journal of Haematology · 2002 · 98 citations

Medicine, Hematology, Pharmacology +9

A randomized, active‐control, pilot trial of front‐loaded dosing regimens of darbepoetin‐alfa for the treatment of patients with anemia during chemotherapy for malignant disease

John A. Glaspy, J Jadeja, Glen R. Justice et al. · Cancer · 2003 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16